KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Bio-Rad Laboratories (BIO) Shares Repurchased (2017 - 2026)

Bio-Rad Laboratories has reported Shares Repurchased over the past 10 years, most recently at $47.8 million for Q1 2026.

  • Quarterly Shares Repurchased fell 53.09% to $47.8 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $241.4 million through Mar 2026, down 19.75% year-over-year, with the annual reading at $295.5 million for FY2025, 45.14% up from the prior year.
  • Shares Repurchased was $47.8 million for Q1 2026 at Bio-Rad Laboratories, down from $53.4 million in the prior quarter.
  • Over five years, Shares Repurchased peaked at $207.4 million in Q2 2023 and troughed at $4.7 million in Q1 2024.
  • The 5-year median for Shares Repurchased is $99.4 million (2024), against an average of $99.3 million.
  • Year-over-year, Shares Repurchased soared 2068.09% in 2025 and then plummeted 53.09% in 2026.
  • A 5-year view of Shares Repurchased shows it stood at $90.7 million in 2022, then soared by 120.48% to $200.0 million in 2023, then crashed by 51.04% to $97.9 million in 2024, then tumbled by 45.45% to $53.4 million in 2025, then dropped by 10.49% to $47.8 million in 2026.
  • Per Business Quant, the three most recent readings for BIO's Shares Repurchased are $47.8 million (Q1 2026), $53.4 million (Q3 2025), and $140.2 million (Q2 2025).